|
|
| Research article summary (published 29 Nov 1991): |
[The thrombolytic therapy of pulmonary embolism]
(La terapia trombolitica dell'embolia polmonare.)
Full Abstract
Recent clinical trials demonstrate that thrombolytic therapy reduces morbidity and mortality of pulmonary embolism compared with heparin anticoagulation. Anticoagulant therapy fail to lyse thrombus that embolizes from the deep leg veins and from the pelvic veins. Anticoagulant therapy is useful in the prevention of recurrent embolism, event if the rate of recurrent embolism is lesser with thrombolytic therapy. Thrombolytic therapy can accelerate clot lysis and pulmonary reperfusion as well as reverse rapidly the associated right heart failure, which is the usual immediate cause of death. The benefit of thrombolytic therapy is easier to appreciate among patients with massive pulmonary embolism. Further trials are necessary to assess the efficacy and the safety of the different dosages of thrombolytic therapy in pulmonary embolism.
Author information
Author/s: Mattioli, A V (AV);
Affiliation: Cattedra di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Modena.
Journal and publication information
Publication Type: English Abstract; Journal Article; Review
Journal: Cardiologia (Rome, Italy) (Cardiologia), published in ITALY. (Language: ita)
Reference: 1991-Dec; vol 36 (issue 12 Suppl 1) : pp 187-93
Dates: Created 1992/12/04; Completed 1992/12/04; Revised 2006/11/15;
PMID: 1841769, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Anticoagulants (0)Related articles
These are the most related articles currently in our database:
- Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry.
29 Jun 2001 - [Fibrinolysis in pulmonary embolism]
18 Oct 2001 - [Diagnosis and therapy of acute pulmonary embolism]
30 Apr 2004 - Paradoxical brain embolism caused by pulmonary arteriovenous fistula and coincident pulmonary embolism--a case report.
30 Aug 2004 - Thrombus aspiration and local fibrinolytic therapy for acute pulmonary thromboembolism.
27 Feb 2007 - [Acute thromboembolism]
4 Oct 2004 - Transthoracic echocardiographic documentation of disappearance of massive pulmonary artery thromboemboli after fibrinolytic therapy.
29 Sep 2002 - Mechanical and enzymatic thrombolysis for massive pulmonary embolism.
30 Jan 2002 - Prognostic factors in medically treated patients with chronic pulmonary embolism.
27 Feb 2001 - Long-term effects of acute pulmonary embolism on echocardiographic Doppler indices and functional capacity.
29 Nov 2004
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.